AM-3876

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAM-3876
Drug Alias Namedual cathepsin S/K inhibitor (Amura)AM-3876
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsNeuralgiaOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmura Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmura Therapeutics
Active IndicationsN/A
Inactive IndicationsNeuralgiaOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A